Tafamidis

DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings

In 2022, the world finally began to emerge out of Covid-related restrictions. Though 2020 and 2021

DMF submissions in 2020: Industry sustains its filing momentum

In case you thought Covid-19 had slowed down the speed at which generic active pharmaceutical ingr

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-